Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
7.90
+0.08 (1.02%)
May 20, 2026, 3:00 PM CST

SHA:600222 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
181.53223.59180.04196.67311.38380.55
Trading Asset Securities
-100.0280.02153.374.96285.67
Cash & Short-Term Investments
181.53323.61260.05349.97386.34666.22
Cash Growth
-55.06%24.44%-25.69%-9.41%-42.01%-4.11%
Accounts Receivable
1,3861,3191,1371,0561,038744.71
Other Receivables
47.6335.6136.3844.0151.1556.44
Receivables
1,4341,3551,1731,1001,089801.15
Inventory
462.7353.83367.67455.5450.49381.85
Other Current Assets
109.28108.96105.3587.88105.0394.49
Total Current Assets
2,1872,1411,9061,9932,0311,944
Property, Plant & Equipment
475.72487.21501.82529.65551.13539.58
Long-Term Investments
473.61472.61526.67520.38490.93825.63
Goodwill
286.49286.49286.49286.49286.49286.49
Other Intangible Assets
48.3349.951.1752.548.1153.1
Long-Term Deferred Tax Assets
98.8297.97113.294.2495.3852.4
Long-Term Deferred Charges
55.156.0452.849.8154.2335.81
Other Long-Term Assets
50.150.151.5550.7149.0847.05
Total Assets
3,6753,6423,4903,5773,6073,784
Accounts Payable
339.63342.59294.89470.29548.89355.65
Accrued Expenses
8.4237.9928.2624.2732.2222.45
Short-Term Debt
609.81507.49663.42381.84404.87973.58
Current Portion of Long-Term Debt
110.78165.1270.0789.764.22158.74
Current Portion of Leases
-12.0146.2935.3526.89-
Current Income Taxes Payable
8.271.251.282.5321.863.7
Current Unearned Revenue
3.392.636.5411.6288.2649.47
Other Current Liabilities
656.54804.56483.76634.5598.8286.09
Total Current Liabilities
1,7371,8741,7951,6501,7261,650
Long-Term Debt
221.5461.763.02183.8192.820.37
Long-Term Leases
32.7224.2242.0489.2937.1472.06
Long-Term Unearned Revenue
2.352.442.783.261.71-
Long-Term Deferred Tax Liabilities
17.6216.9421.1625.3633.26132.42
Other Long-Term Liabilities
---1.621.62131.62
Total Liabilities
2,0111,9791,8641,9531,9932,006
Common Stock
573.89573.89573.89573.89573.89573.89
Additional Paid-In Capital
675.15675.15675.17675.17675.17588.14
Retained Earnings
406.04403.44316.01281.01237.46232.15
Treasury Stock
-109.8-109.8-101.01-79.72-37.66-48.7
Comprehensive Income & Other
60.9661.67110.67128.15121.56315.04
Total Common Equity
1,6061,6041,5751,5781,5701,661
Minority Interest
57.958.1951.5144.8943.62117.13
Shareholders' Equity
1,6641,6631,6261,6231,6141,778
Total Liabilities & Equity
3,6753,6423,4903,5773,6073,784
Total Debt
974.84770.591,025780.03665.921,225
Net Cash (Debt)
-793.31-446.98-764.79-430.07-279.58-558.53
Net Cash Per Share
-1.43-0.81-1.37-0.76-0.50-1.00
Filing Date Shares Outstanding
553.44552.92554.67559.36566.69563.04
Total Common Shares Outstanding
553.44552.92554.67559.36566.69563.04
Working Capital
450.21267.58111.55342.93305.21294.03
Book Value Per Share
2.902.902.842.822.772.95
Tangible Book Value
1,2711,2681,2371,2391,2361,321
Tangible Book Value Per Share
2.302.292.232.222.182.35
Buildings
-558.12556.93543.26534.9520.76
Machinery
-374.14361.45341.92316.19281.14
Construction In Progress
-26.5929.228.931.133.02
Source: S&P Global Market Intelligence. Standard template. Financial Sources.